RelB is a potential molecular biomarker for immunotherapy in human pan-cancer
Abstract Introduction: The nuclear factor kB (NF-κB) pathway emerges as a critical regulator of immune responses and is often dysregulated…
Abstract Introduction: The nuclear factor kB (NF-κB) pathway emerges as a critical regulator of immune responses and is often dysregulated…